Optimize Financial Inc

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 2033266 LAGUNA HILLS, CA

Position in UTHR

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$549,692

+$28,335 QoQ

Shares Held

927

-13.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Optimize Financial Inc holds $2,332,096 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (23.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp This page	927	$549,692
2	LNTH	Lantheus Holdings, Inc.	6,108	$463,291
3	NBIX	Neurocrine Biosciences Inc	3,459	$455,688
4	AMLX	Amylyx Pharmaceuticals, Inc.	32,001	$444,813
5	INDV	Indivior Pharmaceuticals, Inc.	13,734	$418,612

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$549,692	927	-13.4%	Shares	Sole	2026-05-12
2025-12-31	$521,357	1,070	+1.1%	Shares	Sole	2026-02-09
2025-09-30	$443,524	1,058	+65.6%	Shares	Sole	2025-11-05
2024-12-31	$225,464	639	—	Shares	Sole	2025-02-13
No filing history on record for this holder in this stock.